4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-027993
CHIEF ACCOUNTING OFFICER sold 8,646 shares at $22.45 ($194,103)
- CHIEF ACCOUNTING OFFICER acquired 8,646 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-27 | Option exercise 10b5-1 | +8,637 | $11.10 | $95,871 | 35,165 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-27 | Sale 10b5-1 | −8,637 | $22.45 | $193,901 | 26,528 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-29 | Option exercise 10b5-1 | +9 | $11.10 | $100 | 26,537 | D |
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-29 | Sale 10b5-1 | −9 | $22.45 | $202 | 26,528 | D |
| Derivatives | |||||||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-27 | Option exercise · Share Option 10b5-1 | −8,637 | 22,823 | D | ||
| Megna Michael R CHIEF ACCOUNTING OFFICER | 2024-11-29 | Option exercise · Share Option 10b5-1 | −9 | 22,814 | D | ||
| Open-market sales · 8,646 sh · avg $22.45 · $194,103 | |||||||
Loading xslF345X05/form4-12022024_091211.xml…